We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.3B
AUM Growth
+$247M
Cap. Flow
+$141M
Cap. Flow %
6.12%
Top 10 Hldgs %
17.75%
Holding
321
New
26
Increased
135
Reduced
107
Closed
32

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$27M
2
REVG
REV Group
REVG
+$18.6M
3
DBD
Diebold Nixdorf Incorporated
DBD
+$17.2M
4
WGO icon
Winnebago Industries
WGO
+$10.7M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$9.54M

Top Sells

Rank Stock Value
1
CEB
CEB Inc.
CEB
+$22.7M
2
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$20.1M
3
HELE icon
Helen of Troy
HELE
+$20M
4
ALOG
Analogic Corp
ALOG
+$18.5M
5
AMRI
Albany Molecular Research Inc
AMRI
+$17.3M

Sector Composition

Rank Sector Weight
1 Healthcare 20.64%
2 Technology 18.67%
3 Industrials 18.25%
4 Consumer Discretionary 13.65%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCFS icon
76
FirstCash
FCFS
$8.85B
$13.3M 0.58%
228,293
+985
+0.4% +$52.3K
AERI
77
DELISTED
Aerie Pharmaceuticals
AERI
$12.9M 0.56%
244,795
+46,482
+23% +$2.16M
AEIS icon
78
Advanced Energy
AEIS
$11.6B
$12.8M 0.56%
197,807
-87,321
-31% -$6.38M
WIFI
79
DELISTED
Boingo Wireless, Inc.
WIFI
$12.6M 0.55%
838,974
+153,705
+22% +$2.32M
HURN icon
80
Huron Consulting
HURN
$2.41B
$12.4M 0.54%
286,309
+40,949
+17% +$1.76M
KERX
81
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$12.1M 0.52%
1,666,934
+326,285
+24% +$2.04M
PLAY icon
82
Dave & Buster's
PLAY
$377M
$12M 0.52%
180,122
+66,293
+58% +$4.34M
CLVS
83
DELISTED
Clovis Oncology, Inc.
CLVS
$11.8M 0.51%
126,413
+25,487
+25% +$1.56M
STRA icon
84
Strategic Education
STRA
$1.85B
$11M 0.48%
118,484
+44,073
+59% +$3.87M
OXM icon
85
Oxford Industries
OXM
$566M
$10.7M 0.47%
171,281
+44,564
+35% +$2.57M
ACIW icon
86
ACI Worldwide
ACIW
$5.83B
$10.5M 0.46%
469,298
+96,135
+26% +$2.15M
BCPC
87
Balchem Corp
BCPC
$5.38B
$10.2M 0.44%
131,028
-63,566
-33% -$5.07M
IT icon
88
Gartner
IT
$10.1B
$10.1M 0.44%
+81,889
New +$9.5M
ACTA
89
DELISTED
Actua Corp
ACTA
$9.85M 0.43%
700,832
-74,358
-10% -$1.05M
ON icon
90
ON Semiconductor
ON
$31.8B
$9.65M 0.42%
687,137
+129,857
+23% +$1.95M
PGNX
91
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$9.27M 0.4%
1,364,879
+266,763
+24% +$1.97M
PCRX icon
92
Pacira BioSciences
PCRX
$1.04B
$9.24M 0.4%
193,637
+66,444
+52% +$3.08M
BSTC
93
DELISTED
BioSpecifics Technologies Corp.
BSTC
$8M 0.35%
161,671
+31,175
+24% +$1.63M
STGW icon
94
Stagwell
STGW
$2.07B
$7M 0.3%
706,714
+142,503
+25% +$1.23M
ESL
95
DELISTED
Esterline Technologies
ESL
$6.05M 0.26%
63,875
+13,831
+28% +$1.28M
KITE
96
DELISTED
Kite Pharma, Inc.
KITE
$5.98M 0.26%
57,682
+11,840
+26% +$966K
TREX icon
97
Trex
TREX
$4.51B
$5.12M 0.22%
302,820
+64,064
+27% +$1.08M
ZIXI
98
DELISTED
Zix Corporation
ZIXI
$4.82M 0.21%
847,829
-61,406
-7% -$345K
JNJ icon
99
Johnson & Johnson
JNJ
$618B
$4.77M 0.21%
36,083
-550
-2% -$70.2K
CNTY icon
100
Century Casinos
CNTY
$34M
$4.5M 0.2%
610,011
-23,330
-4% -$183K
2 3
4
5 6

Similar funds

GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
EFS
Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return

Rice Hall James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Rice Hall James & Associates held 321 positions worth $2.3B, up 12% from $2.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Rice Hall James & Associates deployed $141M of net new capital in Q2 2017, opening 26 new positions and adding to 135 existing holdings. Its largest new stake was Acadia Healthcare: 610,592 shares worth $30.2M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Advanced Energy, an estimated $6.38M trimmed.

  • Rice Hall James & Associates's largest Q2 2017 buy was Acadia Healthcare: 610,592 shares worth $30.2M.
  • Rice Hall James & Associates added most to Supernus Pharmaceuticals in Q2 2017, an estimated $9.54M increase.
  • Rice Hall James & Associates's biggest Q2 2017 reduction was Advanced Energy, cutting an estimated $6.38M.
  • Rice Hall James & Associates fully exited CEB Inc. in Q2 2017, selling an estimated $22.7M.
  • Rice Hall James & Associates's ten largest holdings make up 18% of its $2.3B portfolio in Q2 2017.
  • Rice Hall James & Associates opened 26 new positions and closed 32 in Q2 2017.
  • Rice Hall James & Associates's portfolio value rose 12% quarter-over-quarter to $2.3B.

Based on Rice Hall James & Associates's 13F filing for Q2 2017, filed 2 Aug 2017.